Effect of Adjunct Hydroxyurea on Helper T Cell Immunity in HIV Type 1-Infected Patients with Virological Suppression
Authors:
- 1 August 2004
- journal article
- research article
- Published by SAGE Publications in AIDS Research and Human Retroviruses
- Vol. 20 (8) , 807-812
Abstract
Hydroxyurea (HU) has preferential activity in virus reservoirs not effectively targeted by current antiretroviral drug regimens, but concern for potential toxicity has precluded its routine use. The effect of adjunct HU on T cell proliferative responses and phenotypic markers was examined in a randomized study of 39 chronically HIV-1-infected patients with virological suppression on potent antiretroviral therapy. While patients in the HU arm showed modest declines in the median CD4+ T cell counts (total, –151 cells/mm3; naive, –91 cells/mm3), no significant differences were noted in the Candida, HIV-1 p24, and HIV-1 gp160 responses between the treatment arms following 24 weeks of therapy. In conclusion, although adjunct HU was associated with modest declines in the CD4+ T cell counts, there was no significant adverse effect on helper T cell function. Further trials to address the role of HU in HIV-1 treatment may be appropriate after careful selection of HU dose and the adjunct drugs to avoid nonhematological toxicity.Keywords
This publication has 15 references indexed in Scilit:
- A cytostatic drug improves control of HIV-1 replication during structured treatment interruptionsAIDS, 2003
- Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2002
- Control of HIV during a structured treatment interruption in chronically infected individuals with vigorous T cell responsesHIV Research & Clinical Practice, 2002
- Complementary Antiviral Efficacy of Hydroxyurea and Protease Inhibitors in Human Immunodeficiency Virus-Infected Dendritic Cells and LymphocytesJournal of Virology, 2002
- Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppressionAIDS, 2001
- Reservoirs for HIV-1: Mechanisms for Viral Persistence in the Presence of Antiviral Immune Responses and Antiretroviral TherapyAnnual Review of Immunology, 2000
- Effects of hydroxyurea on T cell count changes during primary HIV infectionAIDS, 2000
- Effect of Combination Antiretroviral Therapy on T‐Cell Immunity in Acute Human Immunodeficiency Virus Type 1 InfectionThe Journal of Infectious Diseases, 2000
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Hydroxyurea as an Inhibitor of Human Immunodeficiency Virus-Type 1 ReplicationScience, 1994